AstraZeneca reports higher profits after boost from strong cancer drug sales

The FTSE 100-listed firm reported that sales and profit rose 8 and 11%, respectively, in line with its forecasts.

AstraZeneca reports higher profits after boost from strong cancer drug sales
The FTSE 100-listed firm reported that sales and profit rose 8 and 11%, respectively, in line with its forecasts.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow